ARCHIVES

Conversation With The Cancer Letter: PanCAN CEO Denies Bill Would Undermine NCI’s Role in Directing and Funding Research

This article is from The Cancer Letter archive.

Vol. 38 No. 31 | August 3, 2012

Download PDF Visit The Full Archive

Related Articles

Advocacy: Groups Urge studies Of Environmental Pollutants As Cause Of Cancer

November 5, 1999

Satraplatin Improved PFS In Refractory Prostate Cancer

July 25, 2003

NCI Plans $61 Million For Six-Year Program In Biomarker Research For Early Detection

December 4, 1998

(8-page issue).

January 31, 2003

Weekly Paclitaxel, Carboplatin Safer For Advanced Lung Cancer, Study Finds

August 31, 2001

Mouse Strains For Retrovirus Research Available From NCU

March 23, 1984